Carlsmed, Inc. CARL
15.10
0.28
1.89%
as of 25 Sep
- Market cap
- $404.6M
- P/E
- 0.0×
Follow CARL
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (6,196.93%) | (301.61%) | (214.02%) | 0.00% |
+5 more TTM periods Free account |
|
| (42.39%) | (54.90%) | (46.45%) | (32.15%) | ||
ROIC |
(234.53%) | (203.24%) | (442.13%) | (273.81%) | |
Return on Tangible Assets |
(36.49%) | (30.39%) | (26.53%) | (24.65%) | |
Average Days of Receivables |
79.44 | 79.34 | 82.10 | 98.32 | |
Free Cash Flow per Share |
(1.31) | (1.31) | (2.13) | (1.38) | |
Free Cash Flow |
(35.67) | (35.15) | (30.33) | (29.05) | |
Capital Expenditures |
(1.53) | (1.32) | (1.36) | (1.19) | |
Piotroski F-Score |
5.00 | 0.00 | 1.00 | 1.00 | |
| Other line items | |||||
Cash ROIC |
(18.07%) | (16.52%) | (12.93%) | (11.73%) | |
Accounts Receivable Turnover |
5.39 | 5.93 | 5.57 | 0.00 | |
Accounts Payable Turnover |
4.71 | 5.07 | 3.62 | 0.00 | |
Inventory Turnover |
8.85 | 8.90 | 8.78 | 0.00 | |
Average Days of Payables |
91.39 | 79.17 | 131.15 | 91.10 | |
Days of Inventory on Hand |
56.13 | 55.33 | 54.00 | 45.68 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
33.06% | 33.75% | 33.69% | 37.65% | |
Selling, General and Administrative Expense of Revenue |
104.65% | 102.61% | 102.15% | 106.05% | |
Share Based Compensation of Revenue |
8.52% | 5.99% | 3.82% | 2.87% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.94 | 1.04 | 0.96 | 0.93 | |
Depreciation/Fixed assets |
0.17 | 0.21 | 0.19 | 0.19 | |
Capex/Depreciation |
(3.74) | (3.90) | (4.83) | (5.40) | |
Revenue per Share |
2.33 | 2.10 | 3.55 | 1.99 | |
Operating CF per Share |
(1.26) | (1.26) | (2.04) | (1.32) | |
Capex per Share |
(0.06) | (0.05) | (0.10) | (0.06) | |
Capex to Sales |
0.02 | 0.02 | 0.03 | 0.03 | |
Net Profit Margin |
(57.42%) | (57.76%) | (59.82%) | (71.56%) |
Columns are period end dates